Immutep IMMP
NASDAQ IMMP
$3.26 +0.03 (+0.77%)
As of: Oct 21, 2026 · 3:25 PM EDT

Immutep (IMMP) Net Margin (2014 - 2017)

Updated

Immutep's Net Margin was -544.79% in the year ended Jun 30, 2026, up 49.85 percentage points from -594.64% a year earlier.

Analysis

Immutep (IMMP) Net Margin (2014 - 2017) Analysis & Trends

From the year ended Jun 30, 2009 onward, Immutep has reported Net Margin for 14 years.

  • Net Margin shows a four-year change of -544.77 percentage points (years ended Jun 2022 to Jun 2026).
  • The figure for the year ended Jun 30, 2026 marks the highest annual Net Margin since the year ended Jun 30, 2022.
  • Per Business Quant data, Net Margin in earlier years was -594.64% in the year ended Jun 30, 2025 and -0.02% in the year ended Jun 30, 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 30.88%
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 21.86%
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 21.27%
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -8.04%
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 22.65%
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 16.30%
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 23.62%
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -134.51%
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -1.65%
10 Immutep 23.69 Mn -187.33 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2017 -366.03%
Mar 31, 2017 -129.02%
Jun 30, 2016 -1,468.42%
Mar 31, 2016 -687.45%
Jun 30, 2015 -19,101.30%
Jun 30, 2014 -83,767.85%
API Access

Immutep Net Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-margin&ticker=IMMP&period=max&api_key=YOUR_API_KEY